A new study, conducted by researchers at the Perlmutter Cancer Center at New York University Langone Health in New York City, demonstrated how vitamin C might stop blood cancer stem cells from multiplying. That helps block some forms of leukemia from advancing.
Scientists discovered that intravenous treatment with vitamin C promoted DNA demethylation, making cancer stem cells to mature and die. This treatment also stopped blood cancer stem cells that were transplanted from human patients to mice from growing.
Corresponding study author Benjamin Neel, Ph.D., director of the Perlmutter Cancer Center, says: “Our results suggest that high-dose vitamin C – and it’s important to note that this means disease that has to be administered [intravenously] – might have therapeutic benefit in TET2-mutant myelodysplastic syndrome, either alone or in combination with current demethylating therapies and/or PARP inhibitors.”
A team of scientists from the United States announced the development of revolutionary therapies to fight cancer. The results were presented at the summit of the American Association for the Advancement of Science in Washington
According to the study, treatment with genetically modified immune cells (called T-lymphocytes), in almost 90% of cases resulted in a complete recovery of patients who have been diagnosed with cancer of the blood of the last stage.
As noted by one of the study leaders, Professor Stanley Riddell, a new therapy has saved those patients who have not got helped by any of the traditional methods of treatment. Stanley Riddell said that have not found any signs of leukemia in patients, using very accurate technologies.
At the same time, scientists have noted that some patients died after treatment application, so it needs additional tests.
Earlier it was reported that the pharmaceutical companies of the world united for the fight against cancer.